|

Lumason Clinical Trials

2 actively recruiting trials across 2 locations

No change since August 2026

Also known as: Infusion Administration, SonoVue

Pipeline

Phase 1: 1Phase 3: 1

Top Sponsors

  • Children's National Research Institute1
  • Bracco Diagnostics, Inc1

Indications

  • Diffuse Midline Glioma or Diffuse Intrinsic Pontine Glioma1
  • Heart Disease1
  • Ependymoma Recurrent1
  • Brain Tumor, Recurrent1
  • High Grade Gliomas1

West Hills, California1 trial

Lumason® Infusion vs. Bolus Administrations

Interventional Cardiology Medical Group

Phase 3

Washington D.C., District of Columbia1 trial

NgFUS NIVO: NeuroNavigation-Guided Focused Ultrasound With Nivolumab in Relapsed and Progressive DMG and Other High Grade Brain Tumors

Children's National Hospital

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.